Azenta Inc (AZTA)
50.87
-0.47
(-0.92%)
USD |
NASDAQ |
May 17, 16:00
50.86
-0.01
(-0.02%)
After-Hours: 20:00
Azenta Free Cash Flow: 54.97M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | 54.97M |
December 31, 2023 | 32.43M |
September 30, 2023 | -21.95M |
June 30, 2023 | -55.71M |
March 31, 2023 | -500.29M |
December 31, 2022 | -580.55M |
September 30, 2022 | -543.48M |
June 30, 2022 | -530.50M |
March 31, 2022 | -59.42M |
December 31, 2021 | 65.76M |
September 30, 2021 | 97.05M |
June 30, 2021 | 129.70M |
March 31, 2021 | 111.58M |
December 31, 2020 | 10.32M |
September 30, 2020 | -2.058M |
June 30, 2020 | -19.27M |
March 31, 2020 | -6.743M |
December 31, 2019 | 80.46M |
September 30, 2019 | 67.04M |
June 30, 2019 | 70.43M |
March 31, 2019 | 55.98M |
December 31, 2018 | 63.36M |
September 30, 2018 | 61.18M |
June 30, 2018 | 62.19M |
March 31, 2018 | 62.91M |
Date | Value |
---|---|
December 31, 2017 | 68.88M |
September 30, 2017 | 83.31M |
June 30, 2017 | 74.56M |
March 31, 2017 | 70.56M |
December 31, 2016 | 56.50M |
September 30, 2016 | 26.70M |
June 30, 2016 | 18.75M |
March 31, 2016 | 20.56M |
December 31, 2015 | 11.26M |
September 30, 2015 | 27.58M |
June 30, 2015 | 26.84M |
March 31, 2015 | 16.61M |
December 31, 2014 | 42.26M |
September 30, 2014 | 48.26M |
June 30, 2014 | 60.78M |
March 31, 2014 | 68.54M |
December 31, 2013 | 53.74M |
September 30, 2013 | 50.75M |
June 30, 2013 | 28.10M |
March 31, 2013 | 25.24M |
December 31, 2012 | 28.81M |
September 30, 2012 | 27.38M |
June 30, 2012 | 44.35M |
March 31, 2012 | 62.76M |
December 31, 2011 | 68.20M |
Free Cash Flow Range, Past 5 Years
-580.55M
Minimum
Dec 2022
129.70M
Maximum
Jun 2021
-80.01M
Average
4.129M
Median
Free Cash Flow Benchmarks
Harvard Bioscience Inc | 10.81M |
Standard BioTools Inc | -99.88M |
Bionano Genomics Inc | -122.26M |
Akoya Biosciences Inc | -55.62M |
Singular Genomics Systems Inc | -80.25M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 8.356M |
Cash from Investing (Quarterly) | -270.61M |
Cash from Financing (Quarterly) | -74.07M |
Free Cash Flow Per Share (Quarterly) | 0.0276 |
Free Cash Flow to Equity (Quarterly) | 1.529M |
Free Cash Flow to Firm (Quarterly) | 1.529M |
Free Cash Flow Yield | 1.84% |